跳至主要内容
临床试验/CTRI/2023/06/053990
CTRI/2023/06/053990进行中(未招募)Unknown

To compare and assess the safety and effectiveness of Fluticasone furoate + Vilanterol (MDI) with usual care (other ICS + LABA MDI) in patients with asthma in real-world setting.

Zydus Healthcare Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients eligible for medication

排除标准

  • Hypersensitivity to active substance
  • Primary treatment of status asthmatics or acute episodes of asthma where intensive measures are required
  • Pregnant or Lactating females; or female patients of childbearing potential unwilling to use effective contraception

研究者

相似试验